GI Oncology: Targeted Therapy and the Expanding Role of KRAS Inhibitors

17 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
Join Dr. Dina Ioffe of Fox Chase Cancer Center and Dr. Shubham Pant of MD Anderson Cancer Center for a focused discussion on pivotal questions in GI oncology. In this expert clip, they delve into practical strategies for first-line therapy selection, toxicity management, and biomarker testing in pancreatic cancer. The conversation then explores the evolving treatment landscape for biliary tract cancer, including the use of FGFR and HER2-targeted agents. Finally, they share insights on modern neoadjuvant approaches and express excitement for the future of targeted therapies in GI cancers.
This content is intended for healthcare professionals.

Website: https://oncupdates.com/
Mail: [email protected]
X/twitter: https://x.com/OncUpdates

Subscribe to our channel for more expert insights from the forefront of oncology.

#GIOcology #PancreaticCancer #BiliaryCancer #TargetedTherapy #MedicalOncology #PrecisionMedicine
Categoria
Oncology
Commenta per primo questo video.

Prossimo